| 000 | 01271 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516005345.0 | ||
| 264 | 0 | _c20110218 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1527-974X | ||
| 024 | 7 |
_a10.1136/jamia.2010.008607 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNadkarni, Prakash M | |
| 245 | 0 | 0 |
_aDrug safety surveillance using de-identified EMR and claims data: issues and challenges. _h[electronic resource] |
| 260 |
_bJournal of the American Medical Informatics Association : JAMIA _c |
||
| 300 |
_a671-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstatistics & numerical data |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aElectronic Health Records _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Claim Review _xstatistics & numerical data |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xmethods |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aVocabulary, Controlled |
| 773 | 0 |
_tJournal of the American Medical Informatics Association : JAMIA _gvol. 17 _gno. 6 _gp. 671-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jamia.2010.008607 _zAvailable from publisher's website |
| 999 |
_c20264866 _d20264866 |
||